Advertisement

International Journal of Hematology

, Volume 76, Issue 1, pp 69–73 | Cite as

Lineage Conversion From Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia on Rearrangement of the IgH Gene in a Patient with Down Syndrome

  • Kazuya Tsuboi
  • Makoto Yazaki
  • Hiroshi Miwa
  • Shinsuke Iida
  • Shogo Banno
  • Atsushi Wakita
  • Masakazu Nitta
  • Ryuzo Ueda
Review Article

Abstract

A patient with Down syndrome (DS) at the time of diagnosis of acute lymphoblastic leukemia (ALL) had a relapse with acute myeloid leukemia (AML) after 4 years of complete remission. Although the diagnosis was AML, the leukemic blasts at relapse showed an immunoglobulin H rearrangement that turned out to be identical to that of the initial ALL blasts. It is thought that the leukemic precursor cells of this patient had the potential to differentiate into both lymphoid and myeloid lineages. This case is important for investigating target cells for leukemogenesis in DS.

Key words

Down syndrome AML ALL IgH CDRIII 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kobayashi H, Satake N, Maseki N, Sakashita A, Kaneko Y.The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukemia.Br J Haematol.1996;94:105–111.CrossRefPubMedGoogle Scholar
  2. 2.
    Loiseau H, Mechinaud F, Harousseau JL. Clonal hematologic disorders in Down syndrome: a review.J Pediatr Hematol.1995;17: 19–24.CrossRefGoogle Scholar
  3. 3.
    Robinson LL, Nesbit NEJ, Sather HN, et al. Down syndrome and acute leukemia in children: a 10-year retrospective survey from Children’s Cancer Study Group.J Pediatr.1984;105:235–242.CrossRefGoogle Scholar
  4. 4.
    Kojima S, Matsuyama T, Sato T, et al. Down’s syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.Blood.1990;76:2348–2353.PubMedGoogle Scholar
  5. 5.
    Zipursky A, Thorner P, Harven DeE, Christensen H, Doyle J. Myelodysplasia and acute megakaryoblastic leukemia in Down’s syndrome.Leuk Res.1994;18:163–171.CrossRefPubMedGoogle Scholar
  6. 6.
    Creutzig U, Ritter J, Vormoor J, et al. Myelodysplasia and acute myelogenous leukemia in Down’s syndrome: a report of 40 children of the AML-BFM study group.Leukemia.1996;10:1677–1686.PubMedGoogle Scholar
  7. 7.
    Donovan JW, Ladetto M, Zou G, et al. Immunoglobulin heavychain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia.Blood.2000;95: 2651–2658.PubMedGoogle Scholar
  8. 8.
    Milili M, Schiff C, Fougereau M, Tonnelle C. The VDJ repertoire expressed in human pre B cells reflects the selection of bona fide heavy chains.Eur J Immunol.1996;26:63–69.CrossRefPubMedGoogle Scholar
  9. 9.
    Oscier D, Thompsett A, Zhu D, Stevenson F. Differential rate of somatic hypermutation in VH genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities.Blood.1997; 89:4153–4160.PubMedGoogle Scholar
  10. 10.
    Seshi B, Kashyap A, Bennett JM.Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase(+), CD13(—), CD14(—) and CD33(—).Br J Haematol.1992;81:374–377.CrossRefPubMedGoogle Scholar
  11. 11.
    Kawada H, Ichikawa Y, Kobayashi N, Fukuda R, Yonekura S, Nagao T. Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+ CD13 and CD33.Intern Med.1993;32:733–736.CrossRefPubMedGoogle Scholar
  12. 12.
    Khalil SH, Jackson JM, Qari MH, Pyle H. Acute myeloblastic leukemia (AML-M2) expression CD19 B-cell lymphoid antigen without myeloid surface antigens.Leuk Res.1994;18:145.CrossRefPubMedGoogle Scholar
  13. 13.
    Specchia G, Mestice A, Storlazzi T, et al. A novel translocation t(2; 9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative.Leuk Res.2001;25: 501–507.CrossRefPubMedGoogle Scholar
  14. 14.
    Creutzig U, Harbott J, Sperling C, et al. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of AML study 8944.Blood.1995;86:3097–3108.PubMedGoogle Scholar
  15. 15.
    Ravindranath Y, Abella E, Krischer JP, et al. Acute myeloid leukemia (AML) in Down’s syndrome is highly responsive to chemotherapy: experience on pediatric oncology group AML study 8498.Blood.1992;80:2210–2214.PubMedGoogle Scholar
  16. 16.
    Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. t(8; 21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.Proc Natl Acad Sci U S A.1991;88:10431–10434.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Berger R. Acute lymphoblastic leukemia and chromosome 21.Cancer Genet Cytogenet.1997;94:8–12.CrossRefPubMedGoogle Scholar
  18. 18.
    Romana SP, Poirel H, Le Coniat M, et al. High frequency of t(12; 21) in childhood B lineage acute lymphoblastic leukemia.Blood.1995;86:4263–4269.PubMedGoogle Scholar
  19. 19.
    Shurtleff SA, Buijs A, Behm FG, et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.Leukemia.1995;9:1985–1989.PubMedGoogle Scholar
  20. 20.
    Raynaud S, Cavé H, Baens M, et al. The 12;21 translocation involving Tel and deletion of the other Tel allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia.Blood.1996;87:2891–2899.PubMedGoogle Scholar
  21. 21.
    Romana SP, Mauchauffé M, Coniat LeM, et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.Blood.1995;85:3662–3670.PubMedGoogle Scholar
  22. 22.
    Golub TR, Barker GF, Bohlander SK, et al. Fusion of the Tel gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.Proc Natl Acad Sci U S A.1995;92:4917–4921.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Holland WW, Doll R, Carter O. The mortality from leukaemia and other cancers among patients with Down’s syndrome and among their parents.Br J Cancer.1962;16:177–186.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S. AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia.Haematologica.2000;85:362–366.PubMedGoogle Scholar
  25. 25.
    Fong C, Brodeur GM. Down’s syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.Cancer Genet Cytogenet.1987;28:55–76.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2002

Authors and Affiliations

  • Kazuya Tsuboi
    • 1
    • 2
  • Makoto Yazaki
    • 3
  • Hiroshi Miwa
    • 2
  • Shinsuke Iida
    • 1
  • Shogo Banno
    • 1
  • Atsushi Wakita
    • 1
  • Masakazu Nitta
    • 2
  • Ryuzo Ueda
    • 1
  1. 1.Second Department of Internal MedicineNagoya City University Medical SchoolJapan
  2. 2.Department of Internal Medicine, Division of HematologyAichi Medical UniversityAichiJapan
  3. 3.Department of PediatricsNagoya City University Medical SchoolNagoyaJapan

Personalised recommendations